Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT01927081 · ClinicalTrials.gov registry record · NA

Self-management Interventions for Advanced Breast Cancer

A NA study of Advanced Breast Cancer Stage IV, sponsored by Duke University.

Completed
Registry status
NA
Development phase
65
Enrollment target
1
Study location

NCT01927081: Completed NA study of Advanced Breast Cancer Stage IV, sponsored by Duke University.

NCT01927081 is a NA study of Advanced Breast Cancer Stage IV that has completed, run by Duke University. The registered enrollment target is 65 participants, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (95% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT01927081, a NA study of Advanced Breast Cancer Stage IV, has completed, sponsored by Duke University.

COMPLETED
Registry status
NA
Development phase
65 participants
Enrollment target
1
Study location

Study Summary

The purpose of this research study is to evaluate whether self-management discussion groups are helpful for women with advanced breast cancer who are experiencing pain. The study is looking at the usefulness of two different types of discussion groups, one of which also includes gentle exercise.

Primary Outcome

Feasibility will be indicated by our ability to meet accrual goals, and by at least 70% of patients attending ≥4 of 8 sessions and providing post-test assessments

Interventions

  • BEHAVIORAL discussion group
  • BEHAVIORAL gentle exercise

Study Locations (1)

North Carolina

  • Duke University Medical Center - Durham

Trial Details

FieldValue
Enrollment Target 65 participants
Start Date 2014-09
Est. Completion 2017-11-20
Phase NA
Duke University

1,725 total trials

What the finished NCT01927081 record still lists

NCT01927081 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 65 participants, a relatively small participant target, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (95% lower).

The record links to 1 condition, with Advanced Breast Cancer Stage IV appearing as the primary indexed condition, and to 2 interventions - of which discussion group is the first listed.

NCT01927081 reports a single indexed study location in North Carolina.

Frequently Asked Questions

What is clinical trial NCT01927081 about?

NCT01927081 is a clinical study titled "Self-management Interventions for Advanced Breast Cancer". The purpose of this research study is to evaluate whether self-management discussion groups are helpful for women with advanced breast cancer who are experiencing pain. The study is looking at the usefulness of two different types of discussion groups, one of which also includes gentle exercise.

What is the current status of trial NCT01927081?

This trial is currently completed. It is a NA study. The enrollment target is 65 participants. The study started on 2014-09. Estimated completion is 2017-11-20.

What conditions does trial NCT01927081 study?

This clinical trial studies the following conditions: Advanced Breast Cancer Stage IV.

What interventions are being tested in trial NCT01927081?

The interventions under investigation include: discussion group (BEHAVIORAL), gentle exercise (BEHAVIORAL).

Who is sponsoring clinical trial NCT01927081?

This trial is sponsored by Duke University, which has 1,725 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT01927081 being conducted?

This trial has 1 study location across North Carolina. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

How this trial's enrollment target compares

Where NCT01927081's enrollment target sits among peer trials

65 1144th of 2000 higher than 854 of 2,000 other NA trials

participants (enrollment target), bucketed by value

Each bar is a band; taller bars hold more other NA trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.

Source ClinicalTrials.gov registry export · 2026-08-08

Nationwide trials with similar profiles

Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.

Similar enrollment target

  • NCT03366116 · 65 participants · Phase 1

    5-aza-4'-Thio-2'-Deoxycytidine (Aza-TdC) in People With Advanced Solid Tumors

  • NCT03603730 · 65 participants · NA

    Vagal Nerve Stimulation for Functional Dyspepsia and Gastroparesis

  • NCT03796559 · 65 participants · NA

    Magseed Enabled Long-Term Localization of Axillary Lymph Nodes

  • NCT03993106 · 65 participants · Phase 2

    A Study of sEphB4-HSA in Kaposi Sarcoma

Similar registry start date

  • NCT05988463 · started 2027-01-01 · Phase 1

    Dose-Escalation Study of Artesunate Patients With IPF

  • NCT07219706 · started 2026-12-10 · NA

    Dietary Fiber and Time Restricted Eating

  • NCT02831335 · started 2026-12-01

    Technical Development of Multi-Parametric Renocerebral MRI

  • NCT05962346 · started 2026-12 · NA

    Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia

Source: ClinicalTrials.gov NCT01927081, the US trial registry maintained by the National Library of Medicine. NCT01927081 (small enrollment · single site footprint · completed) retrieved and formatted by PlainTrial, see methodology.